NAFAMOSTAT: 94 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
94
Total FAERS Reports
17 (18.1%)
Deaths Reported
40
Hospitalizations
94
As Primary/Secondary Suspect
17
Life-Threatening
Active Ingredient: NAFAMOSTAT MESYLATE ·
First Report: 200211 · Latest Report: 20250811
What Are the Most Common NAFAMOSTAT Side Effects?
#1 Most Reported
Off label use
29 reports (30.9%)
#2 Most Reported
Drug ineffective
11 reports (11.7%)
#3 Most Reported
Covid-19
7 reports (7.4%)
All NAFAMOSTAT Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 29 | 30.9% | 3 | 13 |
| Drug ineffective | 11 | 11.7% | 1 | 5 |
| Anaphylactic shock | 7 | 7.5% | 0 | 4 |
| Covid-19 | 7 | 7.5% | 2 | 5 |
| Hypotension | 6 | 6.4% | 3 | 6 |
| Tremor | 6 | 6.4% | 0 | 0 |
| Acute respiratory distress syndrome | 5 | 5.3% | 3 | 3 |
| Diarrhoea | 5 | 5.3% | 3 | 2 |
| Disseminated intravascular coagulation | 5 | 5.3% | 3 | 3 |
Who Reports NAFAMOSTAT Side Effects? Age & Gender Data
Gender: 44.4% female, 55.6% male. Average age: 64.0 years. Most reports from: JP. View detailed demographics →
Is NAFAMOSTAT Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 1 | 1 | 1 |
| 2014 | 3 | 3 | 0 |
| 2015 | 6 | 0 | 4 |
| 2016 | 5 | 0 | 2 |
| 2017 | 3 | 2 | 2 |
| 2018 | 1 | 0 | 0 |
| 2019 | 2 | 0 | 1 |
| 2020 | 9 | 2 | 6 |
| 2021 | 2 | 0 | 0 |
| 2022 | 1 | 1 | 1 |
| 2024 | 3 | 1 | 2 |
| 2025 | 1 | 0 | 0 |
What Is NAFAMOSTAT Used For?
| Indication | Reports |
|---|---|
| Covid-19 | 25 |
| Product used for unknown indication | 17 |
| Anticoagulant therapy | 13 |
| Covid-19 pneumonia | 8 |
Official FDA Label for NAFAMOSTAT
Official prescribing information from the FDA-approved drug label.